Thursday, 01. December 2022, 1.00 p.m.
Ernst-Abbe-Platz 2, 4. Etage – SR 3423
High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance
Dr. Kathi Zarnack
(Computational RNA Biology, Buchmann Institute for Molecular Life Sciences, Frankfurt/Main Germany)